Tomeki

Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment

Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment

Proceedings of a Workshop

By National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,National Cancer Policy Forum,Sharyl J. Nass

0 (0 Ratings)
0 Want to read0 Currently reading0 Have read

Publish Date

2016

Publisher

National Academies Press

Language

eng

Pages

-

1-3 of 3 Editions

Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment

View Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment

Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment

View Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment

Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment

View Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment